1 Min Read
April 26 (Reuters) - Aclaris Therapeutics Inc
* Aclaris therapeutics announces notice of allowance for a u.s. Patent application covering lead candidate a-101 topical solution Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.